FRE — Fresenius SE & Co. KGaA Share News
0.000.00%
Last trade - 00:00- €26.47bn
- €35.49bn
- €22.87bn
Porr acquires parts of Fresenius' VAMED as Strabag pulls out (updated)
Brief: Fresenius Says Sale In Two Independent Steps Accelerates Divestment Of Vamed’s Austrian Activities
Europe Research Roundup: Craneware, Croda, Genus
Brief: Fresenius Receives A EUR 400 Million EIB Loan To Support Research And Development, Innovation And Capacity Expansion Across EU
Brief: Fresenius Kabi AG Continues Streamlining Operations With Divestment Of Calea Homecare Business In Canada
Brief: Fresenius Divests Calea Homecare Business In Canada
Europe Research Roundup: Euronext, Genuit Group, Melrose Industries
Live Markets: Europe before the bell: bounce continues as earnings please
Brief: Fresenius Q2 EBIT Before Special Items At EUR 654 Million
Fresenius raises 2025 revenue guidance (updated)
Fresenius raises 2025 revenue guidance
Brief: Fresenius SE - Receives European Commission Approval For Denosumab Biosimilars
Nestle chair's exit followed rising unease over direction, investors say
Brief: Fresenius Expands Biopharma Portfolio In U.S. With Denosumab Biosimilars Availability
'In an uncertain world, opportunities abound' - Citi on European health cos
Europe Research Roundup: Allianz, Coloplast, Unilever
Brief: Fresenius SE - Denosumab CHMP Positive Opinion
Brief: Fresenius Expands Its Line Of Epinephrine Injectables In The U.S.
Europe Research Roundup: Aedifica, BASF, Kingfisher